D.A. Davidson & Co. Danaher Corp Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Danaher Corp stock. As of the latest transaction made, D.A. Davidson & Co. holds 13,294 shares of DHR stock, worth $3.12 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,294

Previous 12,951 2.65%

Holding current value

$3.12 Million

Previous $3.24 Million 14.22%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$239.25 - $280.76 $82,062 - $96,300	343 Added 2.65%	13,294 $3.7 Million
Q2 2024 Jul 31, 2024	SELL	$235.51 - $267.98 $51,105 - $58,151	-217 Reduced 1.65%	12,951 $3.24 Million
Q1 2024 May 13, 2024	SELL	$224.58 - $256.19 $108,921 - $124,252	-485 Reduced 3.55%	13,168 $3.29 Million
Q4 2023 Feb 09, 2024	BUY	$185.1 - $233.13 $303,008 - $381,633	1,637 Added 13.62%	13,653 $3.16 Million
Q3 2023 Nov 08, 2023	BUY	$233.08 - $265.59 $247,764 - $282,322	1,063 Added 9.71%	12,016 $2.98 Million
Q2 2023 Aug 10, 2023	SELL	$224.99 - $256.14 $56,472 - $64,291	-251 Reduced 2.24%	10,953 $2.63 Million
Q1 2023 Apr 25, 2023	BUY	$239.75 - $277.0 $236,633 - $273,399	987 Added 9.66%	11,204 $2.82 Million
Q4 2022 Feb 03, 2023	SELL	$241.42 - $282.29 $311,673 - $364,436	-1,291 Reduced 11.22%	10,217 $2.71 Million
Q3 2022 Nov 07, 2022	BUY	$247.06 - $1507.4 $27,917 - $170,336	113 Added 0.99%	11,508 $2.97 Million
Q2 2022 Jul 28, 2022	SELL	$237.11 - $299.66 $69,473 - $87,800	-293 Reduced 2.51%	11,395 $2.89 Million
Q1 2022 May 12, 2022	SELL	$257.27 - $315.76 $5,659 - $6,946	-22 Reduced 0.19%	11,688 $3.43 Million
Q4 2021 Jan 31, 2022	BUY	$292.08 - $329.01 $308,144 - $347,105	1,055 Added 9.9%	11,710 $3.85 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $51,447 - $62,829	-189 Reduced 1.74%	10,655 $3.24 Million
Q2 2021 Aug 10, 2021	BUY	$225.08 - $271.69 $31,961 - $38,579	142 Added 1.33%	10,844 $2.91 Million
Q1 2021 May 07, 2021	SELL	$212.38 - $245.9 $231,494 - $268,031	-1,090 Reduced 9.24%	10,702 $2.41 Million
Q4 2020 Feb 10, 2021	BUY	$212.5 - $245.46 $506,812 - $585,422	2,385 Added 25.35%	11,792 $2.62 Million
Q3 2020 Nov 02, 2020	SELL	$177.16 - $215.33 $153,243 - $186,260	-865 Reduced 8.42%	9,407 $2.03 Million
Q2 2020 Aug 10, 2020	SELL	$128.7 - $176.83 $196,653 - $270,196	-1,528 Reduced 12.95%	10,272 $1.82 Million
Q1 2020 May 05, 2020	SELL	$121.39 - $169.05 $72,348 - $100,753	-596 Reduced 4.81%	11,800 $1.63 Million
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $190,595 - $219,169	1,428 Added 13.02%	12,396 $1.9 Million
Q3 2019 Nov 05, 2019	BUY	$135.4 - $146.47 $154,220 - $166,829	1,139 Added 11.59%	10,968 $1.58 Million
Q2 2019 Aug 13, 2019	SELL	$124.88 - $143.73 $708,943 - $815,955	-5,677 Reduced 36.61%	9,829 $1.41 Million
Q1 2019 May 13, 2019	SELL	$97.62 - $132.29 $117,632 - $159,409	-1,205 Reduced 7.21%	15,506 $2 Million
Q4 2018 Jan 29, 2019	BUY	$94.85 - $109.54 $5,406 - $6,243	57 Added 0.34%	16,711 $1.72 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $82,919 - $92,020	845 Added 5.35%	16,654 $1.81 Million
Q2 2018 Aug 02, 2018	BUY	$96.1 - $103.24 $168,367 - $180,876	1,752 Added 12.46%	15,809 $1.56 Million
Q1 2018 May 04, 2018	BUY	$92.16 - $103.8 $62,945 - $70,895	683 Added 5.11%	14,057 $1.38 Million
Q4 2017 Feb 08, 2018	BUY	$85.26 - $94.62 $46,722 - $51,851	548 Added 4.27%	13,374 $1.24 Million
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $222,884 - $248,632	2,811 Added 28.07%	12,826 $1.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	10,015	10,015 $0

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account